Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma
Clinical trial NCT04605185 · UNKNOWN
Trial details
- NCT number
- NCT04605185
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-08
- Primary completion
- 2024-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.